Cargando…
Pre-exposure chemoprophylaxis for HIV: It is time
The HIV-1 plague continues unabatedly across sub-Saharan Africa. In Botswana and Swaziland, nearly 40% of the entire adult population is already infected. No current program is capable of slowing the advancing tide. An effective vaccine and widespread treatment are years, if not, decades away. In th...
Autor principal: | Smith, Stephen M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC478616/ https://www.ncbi.nlm.nih.gov/pubmed/15238164 http://dx.doi.org/10.1186/1742-4690-1-16 |
Ejemplares similares
-
Role of the pharmacist in pre-exposure chemoprophylaxis (PrEP) therapy for HIV prevention
por: Clauson, Kevin A., et al.
Publicado: (2009) -
The attrition rate of licensed chiropractors in California: an exploratory ecological investigation of time-trend data
por: Foreman, Stephen M, et al.
Publicado: (2010) -
A novel trifunctional IgG-like bispecific antibody to inhibit HIV-1 infection and enhance lysis of HIV by targeting activation of complement
por: Jia, Leili, et al.
Publicado: (2010) -
Pre-docking filter for protein and ligand 3D structures
por: Wilantho, Alisa, et al.
Publicado: (2008) -
Integration of pre-normalized microarray data using quantile correction
por: Yoneya, Takashi, et al.
Publicado: (2011)